A Clinician’s Guide to Cardiovascular Epidemiology and Clinical Outcomes Trials Maki, Kevin C. editor. edt http://id.loc.gov/vocabulary/relators/edt Wilson, Don P. editor. edt http://id.loc.gov/vocabulary/relators/edt SpringerLink (Online service) text sz 2024 1st ed. 2024. monographic eng

electronic

electronic resource

access XVI, 438 p. 34 illus., 30 illus. in color. online resource. This book provides clinicians with the information needed to effectively interpret the literature from observational and interventional cardiovascular outcomes studies. The book begins by providing a historical context of cardiovascular epidemiology, followed by chapters addressing key concepts in the study of cardiovascular disease such as the types of cardiovascular outcomes studies, basic and evolving design and statistical considerations, current guidelines for reducing atherosclerotic cardiovascular disease risk, surrogate markers of cardiovascular disease, challenges in developing evidence-based recommendations for non-pharmacological interventions, an overview of the pharmaceutical development process, and a detailed discussion of the clinical evidence supporting several factors and their relationships with atherosclerotic cardiovascular disease (lipids, inflammation, hemostasis, heart rhythm, blood pressure, diabetes, obesity, and chronic kidney disease). Cardiovascular Outcomes Research is a must-have resource for physicians and other clinicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention. . Chapter 1. History of Cardiovascular Epidemiology -- Chapter 2. Types of Cardiovascular Outcomes Studies -- Chapter 3. Basic Statistical Considerations for Cardiovascular Outcomes Studies -- Chapter 4. Evolving Concepts in Cardiovascular Outcomes Studies -- Chapter 5. Current Guidelines for Atherosclerotic Cardiovascular Disease Risk Reduction -- Chapter 6. Surrogate Markers of Cardiovascular Disease -- Chapter 7. Challenges in Developing Evidence-based Recommendations for Non-pharmacological Interventions for Atherosclerotic Cardiovascular Disease Risk Reduction -- Chapter 8. Overview of the Pharmaceutical Development Process for Agents to Influence Cardiovascular Health -- Chapter 9. Lipids and Cardiovascular Outcomes -- Chapter 10. Inflammation and Cardiovascular Outcomes -- Chapter 11. Hemostasis and Cardiovascular Outcomes -- Chapter 12. Cardiac Rhythms and Cardiovascular Outcomes -- Chapter 13. Blood Pressure and CardiovascularOutcomes -- Chapter 14. Diabetes, Obesity, Metabolic Syndrome and Cardiovascular Outcomes -- Chapter 15. Chronic Kidney Disease and Cardiovascular Outcomes. . edited by Kevin C. Maki, Don P. Wilson. Cardiology Epidemiology Medicine Research Biology Research Cardiology Epidemiology Biomedical Research RC666-701.2 9783031549601 https://doi.org/10.1007/978-3-031-54960-1 https://doi.org/10.1007/978-3-031-54960-1 240523 20251030112055.0 978-3-031-54960-1